Published in
Esmo Open, Esmo Open, 2(6), p. 100089, 2021
DOI: 10.1016/j.esmoop.2021.100089
Links
Tools
An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancer
Journal article published in 2021 by
A. Thiery-Vuillemin,
K. Fizazi,
O. Sartor,
S. Oudard 
,
D. Bury,
K. Thangavelu,
A. Ozatilgan,
E. M. Poole,
M. Eisenberger,
J. de Bono
,
D. Bury,
K. Thangavelu,
A. Ozatilgan,
E. M. Poole,
M. Eisenberger,
J. de Bono
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 